Richard A Mostardi

US Patent:

20040102293, May 27, 2004

Filed:

Nov 25, 2002

Appl. No.:

10/303561

Inventors:

Richard Mostardi - Ravenna OH, US

International Classification:

A63B026/00
A63B021/002

US Classification:

482/091000, 482/023000

Abstract:

A soft, durable, inflatable, exercise device, preferably trapezoidal in shape is provided to enable a user to apply compressive isometric forces against the device to train, strengthen and/or condition major muscles and muscle groups of the human body.

US Patent:

20120184609, Jul 19, 2012

Filed:

Jul 19, 2010

Appl. No.:

13/384574

Inventors:

James M. Jamison - Stow OH, US
Thomas M. Miller - El Cajon CA, US
Deborah R. Neal - Uniontown OH, US
Mark Willam Kovacik - Mogadore OH, US
Michael John Askew - Strongsville OH, US
Richard Albert Mostardi - Ravenna OH, US

Assignee:

SUMMA HEALTH SYSTEM - Akron OH

International Classification:

A61K 31/375
A61P 19/08

US Classification:

514474

Abstract:

Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.

US Patent:

20130178522, Jul 11, 2013

Filed:

Jul 19, 2011

Appl. No.:

13/811234

Inventors:

James M. Jamison - Stow OH, US
Deborah R. Neal - Uniontown OH, US
Mark William Kovacik - Mogadore OH, US
Michael John Askew - Strongsville OH, US
Richard Albert Mostardi - Ravenna OH, US
Karen M. McGuire - Akron OH, US
Thomas M. Miller - El Cajon CA, US
Tetyana V. Masyuk - Rochester MN, US
Nicholas F. LaRusso - Rochester MN, US

International Classification:

A61K 31/341
A61K 31/185
A61K 31/255
A61K 31/122

US Classification:

514474

Abstract:

Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NFKB-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K.

US Patent:

20150250760, Sep 10, 2015

Filed:

May 19, 2015

Appl. No.:

14/716587

Inventors:

- Akron OH, US
Thomas M. MILLER - Las Vegas NV, US
Deborah R. NEAL - Uniontown OH, US
Mark William KOVACIK - Mogadore OH, US
Michael John ASKEW - Strongsville OH, US
Richard Albert MOSTARDI - Ravenna OH, US

International Classification:

A61K 31/375
A61K 31/185
A61K 31/122

Abstract:

Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.